PE20141676A1 - Composiciones de yodo-povidona estable - Google Patents
Composiciones de yodo-povidona estableInfo
- Publication number
- PE20141676A1 PE20141676A1 PE2014000281A PE2014000281A PE20141676A1 PE 20141676 A1 PE20141676 A1 PE 20141676A1 PE 2014000281 A PE2014000281 A PE 2014000281A PE 2014000281 A PE2014000281 A PE 2014000281A PE 20141676 A1 PE20141676 A1 PE 20141676A1
- Authority
- PE
- Peru
- Prior art keywords
- povidone
- composition
- iodine
- stable iodine
- alcohol
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/785—Polymers containing nitrogen
- A61K31/787—Polymers containing nitrogen containing heterocyclic rings having nitrogen as a ring hetero atom
- A61K31/79—Polymers of vinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N59/00—Biocides, pest repellants or attractants, or plant growth regulators containing elements or inorganic compounds
- A01N59/12—Iodine, e.g. iodophors; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/18—Iodine; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0046—Ear
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Abstract
SE REFIERE A UNA COMPOSICION QUE COMPRENDE: a) YODO-POVIDONA (PVP-I) A UNA CONCENTRACION DE 0,4% Y 12,5% EN PESO; Y b) UN SEGUNDO COMPONENTE SELECCIONADO DE: (i) UN ANTIINFLAMATORIO NO ESTEROIDE (NSAID) TAL COMO FUMARATO DE KETOTIFEN, DICLOFENAC SODICO, KETOROLAC, TROMETAMINA, SUPROFENO, ENTRE OTROS, Y (ii) UN ESTEROIDE TAL COMO MEDRISONA, DEXAMETASONA, ALCOHOL DE DEXAMETASONA, ACETATO DE PREDNISOLONA, HIDROCORTISONA, ENTRE OTROS. DICHA COMPOSICION ES UTIL PARA EL TRATAMIENTO DE UNA INFECCION OTICA
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201161535667P | 2011-09-16 | 2011-09-16 |
Publications (1)
Publication Number | Publication Date |
---|---|
PE20141676A1 true PE20141676A1 (es) | 2014-11-06 |
Family
ID=47883771
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PE2014000281A PE20141676A1 (es) | 2011-09-16 | 2012-09-14 | Composiciones de yodo-povidona estable |
Country Status (16)
Country | Link |
---|---|
US (1) | US20150164939A1 (es) |
EP (2) | EP2755477A4 (es) |
JP (3) | JP6539444B2 (es) |
KR (2) | KR20190099084A (es) |
CN (2) | CN107595879A (es) |
AR (1) | AR087857A1 (es) |
AU (2) | AU2012308424B2 (es) |
BR (1) | BR112014005487A2 (es) |
CA (1) | CA2847364C (es) |
CL (2) | CL2014000592A1 (es) |
CO (1) | CO6930368A2 (es) |
EC (1) | ECSP14013302A (es) |
MX (1) | MX2014002679A (es) |
PE (1) | PE20141676A1 (es) |
TW (4) | TW201808311A (es) |
WO (1) | WO2013040347A1 (es) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101967938B1 (ko) * | 2011-05-12 | 2019-04-10 | 포어사이트 바이오쎄라퓨틱스, 인코퍼레이티드 | 스테로이드 또는 비-스테로이드성 소염제를 갖는 안정한 포비돈-요오드 조성물 |
US11596599B2 (en) | 2012-05-03 | 2023-03-07 | The Johns Hopkins University | Compositions and methods for ophthalmic and/or other applications |
CA2871745C (en) | 2012-05-03 | 2023-01-24 | Kala Pharmaceuticals, Inc. | Pharmaceutical nanoparticles showing improved mucosal transport |
US9827191B2 (en) | 2012-05-03 | 2017-11-28 | The Johns Hopkins University | Compositions and methods for ophthalmic and/or other applications |
KR102140989B1 (ko) | 2012-05-03 | 2020-08-04 | 칼라 파마슈티컬스, 인크. | 개선된 점막 수송을 나타내는 제약 나노입자 |
JP6669499B2 (ja) | 2013-02-15 | 2020-03-18 | カラ ファーマシューティカルズ インコーポレイテッド | 治療用化合物 |
JP2016510000A (ja) | 2013-02-20 | 2016-04-04 | カラ ファーマシューティカルズ インコーポレイテッド | 治療用化合物およびその使用 |
US9688688B2 (en) | 2013-02-20 | 2017-06-27 | Kala Pharmaceuticals, Inc. | Crystalline forms of 4-((4-((4-fluoro-2-methyl-1H-indol-5-yl)oxy)-6-methoxyquinazolin-7-yl)oxy)-1-(2-oxa-7-azaspiro[3.5]nonan-7-yl)butan-1-one and uses thereof |
US9890173B2 (en) | 2013-11-01 | 2018-02-13 | Kala Pharmaceuticals, Inc. | Crystalline forms of therapeutic compounds and uses thereof |
KR20160099084A (ko) | 2013-11-01 | 2016-08-19 | 칼라 파마슈티컬스, 인크. | 치료 화합물의 결정질 형태 및 그의 용도 |
EP3365022A4 (en) * | 2015-10-25 | 2019-07-24 | IVIEW Therapeutics, Inc. | PHARMACEUTICAL FORMULATIONS THAT FORM A GEL IN SITU |
CA3036340A1 (en) | 2016-09-08 | 2018-03-15 | Kala Pharmaceuticals, Inc. | Crystalline forms of therapeutic compounds and uses thereof |
AU2017324251A1 (en) | 2016-09-08 | 2019-03-21 | Kala Pharmaceuticals, Inc. | Crystalline forms of therapeutic compounds and uses thereof |
US10253036B2 (en) | 2016-09-08 | 2019-04-09 | Kala Pharmaceuticals, Inc. | Crystalline forms of therapeutic compounds and uses thereof |
JP6255134B1 (ja) * | 2016-11-02 | 2017-12-27 | ヴェローチェ・バイオファーマ・エルエルシー | 耳炎の治療のための組成物および方法 |
EP3612228B1 (en) * | 2017-04-21 | 2023-08-23 | Dermaliq Therapeutics, Inc. | Iodine compositions |
CN110559175A (zh) * | 2019-08-27 | 2019-12-13 | 陈文龙 | 一种结膜囊消毒溶液及其使用方法和装置 |
US20230181625A1 (en) * | 2021-12-14 | 2023-06-15 | Harrow Ip, Llc | Method and composition for treating infectious conjunctivitis |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3886268A (en) | 1972-05-30 | 1975-05-27 | Synergistics | Iodophor-steroid compound pharmaceutical compositions |
US4113857A (en) | 1977-05-16 | 1978-09-12 | The Purdue Frederick Company | Process for the preparation of iodophor compounds and methods for stabilizing iodophor pharmaceutical compositions containing the same |
US4954351A (en) * | 1983-03-02 | 1990-09-04 | Euroceltique S.A. | Method of producing standardized povidone iodine preparations and such preparations |
US4996048A (en) | 1988-11-30 | 1991-02-26 | Euroceltique, S.A. | Stabilizing packaged iodophor and minimizing leaching of iodine through packaging |
US5232692A (en) * | 1989-04-28 | 1993-08-03 | Research And Education Institute, Inc. | Povidone-iodine neonatal ophthalmic antimicrobial prophylactic agent |
US5126127A (en) | 1991-07-16 | 1992-06-30 | Euroceltique, S.A. | Stabilized PVP-I solutions |
IL135222A (en) * | 2000-03-22 | 2005-06-19 | Univ Ben Gurion | Compositions containing molecular iodine |
WO2003092669A2 (en) * | 2002-05-03 | 2003-11-13 | Alcon, Inc. | Method of treating vascular endothelial growth factor mediated vascular disorders using amfenac or nepafenac |
US20060280809A1 (en) * | 2005-06-14 | 2006-12-14 | Leshchiner Adele K | Anti-infective iodine based compositions for otic and nasal use |
US7767217B2 (en) * | 2006-03-14 | 2010-08-03 | Foresight Biotherapeutics | Ophthalmic compositions comprising povidone-iodine |
US20090092574A1 (en) * | 2006-12-29 | 2009-04-09 | Scott Richard W | Ophthalmic And Otic Compositions Of Facially Amphiphilic Polymers And Oligomers And Uses Thereof |
WO2009071594A1 (en) * | 2007-12-04 | 2009-06-11 | Novagali Pharma Sa | Compositions comprising corticosteroid prodrug such as dexamethasone palmitate for the treatment of eye disorders |
US20090263345A1 (en) * | 2008-01-28 | 2009-10-22 | Foresight Biotherapeutics, Inc. | Otic compositions for the treatment of infections of the internal and external ear in mammals |
CN101965183A (zh) * | 2008-02-21 | 2011-02-02 | 伊斯塔药品公司 | 作为佐剂的眼用nsaid |
AU2009258145A1 (en) * | 2008-06-12 | 2009-12-17 | Foresight Biotherapeutics, Inc. | Povidone iodine, a novel alternative preservative for ophthalmic compositions |
JP2010059058A (ja) * | 2008-09-01 | 2010-03-18 | Kowa Co | 鎮痛・抗炎症剤含有外用剤 |
JP5410071B2 (ja) * | 2008-10-07 | 2014-02-05 | 久光製薬株式会社 | エステル化抑制剤及びエステル化抑制方法 |
TWI618539B (zh) * | 2009-12-15 | 2018-03-21 | 遠景生物製藥股份有限公司 | 無刺激性眼用聚乙烯吡咯啶酮-碘組成物 |
KR101967938B1 (ko) * | 2011-05-12 | 2019-04-10 | 포어사이트 바이오쎄라퓨틱스, 인코퍼레이티드 | 스테로이드 또는 비-스테로이드성 소염제를 갖는 안정한 포비돈-요오드 조성물 |
-
2012
- 2012-09-12 TW TW106117653A patent/TW201808311A/zh unknown
- 2012-09-12 TW TW101133293A patent/TW201325601A/zh unknown
- 2012-09-12 TW TW109131376A patent/TW202126313A/zh unknown
- 2012-09-12 TW TW108128617A patent/TW202023575A/zh unknown
- 2012-09-13 AR ARP120103368A patent/AR087857A1/es not_active Application Discontinuation
- 2012-09-14 EP EP12832369.8A patent/EP2755477A4/en not_active Ceased
- 2012-09-14 WO PCT/US2012/055402 patent/WO2013040347A1/en active Application Filing
- 2012-09-14 CA CA2847364A patent/CA2847364C/en not_active Expired - Fee Related
- 2012-09-14 MX MX2014002679A patent/MX2014002679A/es unknown
- 2012-09-14 CN CN201710952018.5A patent/CN107595879A/zh active Pending
- 2012-09-14 PE PE2014000281A patent/PE20141676A1/es not_active Application Discontinuation
- 2012-09-14 KR KR1020197023612A patent/KR20190099084A/ko not_active IP Right Cessation
- 2012-09-14 CN CN201280049825.1A patent/CN103889218A/zh active Pending
- 2012-09-14 BR BR112014005487A patent/BR112014005487A2/pt not_active IP Right Cessation
- 2012-09-14 JP JP2014530828A patent/JP6539444B2/ja not_active Expired - Fee Related
- 2012-09-14 KR KR1020147008755A patent/KR20140077900A/ko active Application Filing
- 2012-09-14 EP EP19159190.8A patent/EP3556372A1/en not_active Withdrawn
- 2012-09-14 AU AU2012308424A patent/AU2012308424B2/en not_active Ceased
-
2014
- 2014-03-12 CL CL2014000592A patent/CL2014000592A1/es unknown
- 2014-04-11 EC ECSP14013302 patent/ECSP14013302A/es unknown
- 2014-04-14 CO CO14080461A patent/CO6930368A2/es not_active Application Discontinuation
-
2015
- 2015-02-20 US US14/627,262 patent/US20150164939A1/en not_active Abandoned
-
2016
- 2016-07-07 AU AU2016204700A patent/AU2016204700B2/en not_active Ceased
-
2017
- 2017-07-31 CL CL2017001952A patent/CL2017001952A1/es unknown
- 2017-09-14 JP JP2017176459A patent/JP2018024689A/ja not_active Ceased
-
2019
- 2019-08-19 JP JP2019149911A patent/JP2020007324A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
MX2014002679A (es) | 2014-04-25 |
JP2018024689A (ja) | 2018-02-15 |
EP2755477A4 (en) | 2015-05-06 |
CA2847364A1 (en) | 2013-03-21 |
TW201325601A (zh) | 2013-07-01 |
AR087857A1 (es) | 2014-04-23 |
KR20190099084A (ko) | 2019-08-23 |
US20150164939A1 (en) | 2015-06-18 |
JP2020007324A (ja) | 2020-01-16 |
CO6930368A2 (es) | 2014-04-28 |
CL2014000592A1 (es) | 2014-11-03 |
CN103889218A (zh) | 2014-06-25 |
CA2847364C (en) | 2020-08-25 |
TW202126313A (zh) | 2021-07-16 |
EP2755477A1 (en) | 2014-07-23 |
TW201808311A (zh) | 2018-03-16 |
JP2014526514A (ja) | 2014-10-06 |
ECSP14013302A (es) | 2014-05-31 |
BR112014005487A2 (pt) | 2017-03-21 |
AU2012308424A1 (en) | 2013-05-02 |
KR20140077900A (ko) | 2014-06-24 |
CL2017001952A1 (es) | 2018-03-16 |
EP3556372A1 (en) | 2019-10-23 |
TW202023575A (zh) | 2020-07-01 |
CN107595879A (zh) | 2018-01-19 |
WO2013040347A1 (en) | 2013-03-21 |
AU2016204700B2 (en) | 2018-03-22 |
JP6539444B2 (ja) | 2019-07-03 |
AU2016204700A1 (en) | 2016-07-21 |
AU2012308424B2 (en) | 2016-08-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PE20141676A1 (es) | Composiciones de yodo-povidona estable | |
CO7180221A2 (es) | Composiciones fungicidas | |
CR20140305A (es) | Novedosas dihidropirimidinoisoquinolinonas y composiciones farmacéuticas de las mismas para el tratamiento de transtornos inflamatorios | |
GT201400111A (es) | Triazolopiridinas sustituidas | |
EA201400537A1 (ru) | 18-МЕТИЛ-6,7-МЕТИЛЕН-3-ОКСО-17-ПРЕГН-4-ЕН-21,17β-КАРБОЛАКТОНЫ, ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ, СОДЕРЖАЩИЕ УКАЗАННЫЕ СОЕДИНЕНИЯ, И ИХ ПРИМЕНЕНИЕ В ЛЕЧЕНИИ ЭНДОМЕТРИОЗА | |
EA201590053A1 (ru) | Модуляторы пути системы комплемента и их применение | |
PE20150092A1 (es) | Composiciones farmaceuticas que contienen fumarato de dimetilo | |
ECSP14013231A (es) | Imidazopiridazinas sustituidas con amino | |
CL2012002067A1 (es) | Composición herbicida que contiene una cantidad efectiva de una mezcla herbicida que contiene aminopyralid y 2,4-diclorofenoxiacético; dicha mezcla herbicida; y método para controlar vegetación no deseada, por ejemplo, en el arroz. | |
PE20141152A1 (es) | Triterpenoides c-17 y c-3 modificados con actividad inhibidora de la maduracion del virus de inmunodeficiencia humana | |
ECSP099552A (es) | Compuestos triciclicos, composiciones y procedimientos | |
NI201300068A (es) | Moduladores del receptor de glucagón | |
CR20130569A (es) | Análogos del ácido epoxieicosatrienoicos y métodos de toma y uso del mismo | |
CO6741223A2 (es) | Derivados de azetidina útiles para el tratamiento de enfermedades metabólicas e inflamatorias | |
UA113620C2 (xx) | Композиція, що містить аморфну (5-фтор-2-метил-3-хінолін-2-ілметиліндол-1-іл)оцтову кислоту | |
AR089269A1 (es) | Composiciones para el cuidado oral | |
UY34166A (es) | Composición farmacéutica oftalmológica tópica que contiene regorafenib | |
MX367926B (es) | Composicion farmaceutica para liberacion sostenida de lanreotida. | |
AR084832A1 (es) | Derivado cristalino de oxazina | |
EA201490573A1 (ru) | Соединение бензотиазолона | |
FR2980709B1 (fr) | Compositions contenant de la spermine et compositions pharmaceutiques les contenant | |
CU20130004A7 (es) | Agentes terapéuticos 976 | |
BR112012029565A2 (pt) | composição farmacêutica de liberação controlada de losartana. | |
EA201690236A1 (ru) | Производные индол-3-карбинола | |
PH12016501098A1 (en) | Polymorphic and amorphous forms of cortisol 17-alpha-benzoate and methods for the preparation and use thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC | Refusal |